Cargando…
Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS/hypoproliferative AML
This study aimed to explore the effects of recombinant human thrombopoietin (rhTPO) on platelet recovery in decitabine, cytarabine, aclarubicin, and G-CSF (DCAG)-treated patients with intermediate-high-risk myelodysplastic syndrome/hypo proliferative acute myeloid leukemia. METHODS: Recruited patien...
Autores principales: | Chen, Xiangli, Wang, Yacai, Zang, Yuzhu, Wei, Zhenghong, Zhang, Wenhui, Wei, Xiuli, Luo, Guangli, Chen, Li, Zhang, Yin, Xu, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063278/ https://www.ncbi.nlm.nih.gov/pubmed/37000082 http://dx.doi.org/10.1097/MD.0000000000033373 |
Ejemplares similares
-
IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020) -
The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis
por: Yang, Yuan, et al.
Publicado: (2019) -
Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study
por: Wang, Guorong, et al.
Publicado: (2017) -
Impact of iron overload on poor graft function after allo-HSCT in a patient with transfusion-dependent low-risk MDS: A case report and literature review
por: Wang, Cong, et al.
Publicado: (2022) -
Efficacy and safety of selinexor in the treatment of AML: A protocol for systematic review and meta-analysis
por: Yu, Liming, et al.
Publicado: (2021)